124 related articles for article (PubMed ID: 33261851)
21. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
[TBL] [Abstract][Full Text] [Related]
22. Impact of KRAS status on tumor response and survival after neoadjuvant treatment of locally advanced rectal cancer.
Zhou P; Goffredo P; Ginader T; Thompson D; Hrabe J; Gribovskaja-Rupp I; Kapadia M; Hassan I
J Surg Oncol; 2021 Jan; 123(1):278-285. PubMed ID: 33022750
[TBL] [Abstract][Full Text] [Related]
23. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
[TBL] [Abstract][Full Text] [Related]
24. Low risk of pelvic sepsis after intersphincteric proctectomy in patients with low rectal cancer.
Eriksen MH; Maina P; Jensen KH
Dan Med J; 2014 Dec; 61(12):A4972. PubMed ID: 25441730
[TBL] [Abstract][Full Text] [Related]
25. Combined Proctectomy and Hepatectomy for Metastatic Rectal Cancer Should be Undertaken with Caution: Results of a National Cohort Study.
Concors SJ; Vining CM; Saur NM; Roses RE; Paulson EC
Ann Surg Oncol; 2019 Nov; 26(12):3972-3979. PubMed ID: 31201596
[TBL] [Abstract][Full Text] [Related]
26. Local Excision Versus Radical Resection for 1- to 2-cm Neuroendocrine Tumors of the Rectum: A National Cancer Database Analysis.
Fields AC; Saadat LV; Scully RE; Davids JS; Goldberg JE; Bleday R; Melnitchouk N
Dis Colon Rectum; 2019 Apr; 62(4):417-421. PubMed ID: 30394988
[TBL] [Abstract][Full Text] [Related]
27. Is extralevator abdominoperineal resection necessary for low rectal carcinoma in the neoadjuvant chemoradiotherapy era?
Güven HE; Aksel B
Acta Chir Belg; 2020 Oct; 120(5):334-340. PubMed ID: 31250735
[No Abstract] [Full Text] [Related]
28. Persistent High Rate of Positive Margins and Postoperative Complications After Surgery for cT4 Rectal Cancer at a National Level.
de Nes LCF; Drager LD; Verstegen MG; Burger JWA; Tanis PJ; de Wilt JHW;
Dis Colon Rectum; 2021 Apr; 64(4):389-398. PubMed ID: 33651005
[TBL] [Abstract][Full Text] [Related]
29. Effect of including cancer-specific variables on risk-adjusted hospital surgical quality comparisons.
Merkow RP; Bentrem DJ; Winchester DP; Stewart AK; Ko CY; Bilimoria KY
Ann Surg Oncol; 2013 Jun; 20(6):1766-73. PubMed ID: 23354565
[TBL] [Abstract][Full Text] [Related]
30. Platelet and Neutrophil Counts as Predictive Markers of Neoadjuvant Therapy Efficacy in Rectal Cancer.
Policicchio A; Mercier J; Digklia A; Voutsadakis IA
J Gastrointest Cancer; 2019 Dec; 50(4):894-900. PubMed ID: 30353366
[TBL] [Abstract][Full Text] [Related]
31. Rectal prolapse in the elderly: trends in surgical management and outcomes from the American College of Surgeons National Surgical Quality Improvement Program database.
Clark CE; Jupiter DC; Thomas JS; Papaconstantinou HT
J Am Coll Surg; 2012 Nov; 215(5):709-14. PubMed ID: 22917645
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for post-discharge venous thromboembolism in patients undergoing colorectal resection: a NSQIP analysis.
Alhassan N; Trepanier M; Sabapathy C; Chaudhury P; Liberman AS; Charlebois P; Stein BL; Lee L
Tech Coloproctol; 2018 Dec; 22(12):955-964. PubMed ID: 30569263
[TBL] [Abstract][Full Text] [Related]
33. Is a diverting ostomy needed in mid-high rectal cancer patients undergoing a low anterior resection after neoadjuvant chemoradiation? An NSQIP analysis.
Messaris E; Connelly TM; Kulaylat AN; Miller J; Gusani NJ; Ortenzi G; Wong J; Bhayani N
Surgery; 2015 Sep; 158(3):686-91. PubMed ID: 26008960
[TBL] [Abstract][Full Text] [Related]
34. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
35. Considering Value in Rectal Cancer Surgery: An Analysis of Costs and Outcomes Based on the Open, Laparoscopic, and Robotic Approach for Proctectomy.
Silva-Velazco J; Dietz DW; Stocchi L; Costedio M; Gorgun E; Kalady MF; Kessler H; Lavery IC; Remzi FH
Ann Surg; 2017 May; 265(5):960-968. PubMed ID: 27232247
[TBL] [Abstract][Full Text] [Related]
36. Clinical implications of acellular mucin pools in resected rectal cancer with pathological complete response to neoadjuvant chemoradiation.
de Campos-Lobato LF; Dietz DW; Stocchi L; Vogel JD; Lavery IC; Goldblum JR; Skacel M; Pelley RJ; Kalady MF
Colorectal Dis; 2012 Jan; 14(1):62-7. PubMed ID: 21176057
[TBL] [Abstract][Full Text] [Related]
37. Does transanal local resection increase morbidity for subsequent total mesorectal excision for early rectal cancer?
Coton C; Lefevre JH; Debove C; Creavin B; Chafai N; Tiret E; Parc Y
Colorectal Dis; 2019 Jan; 21(1):15-22. PubMed ID: 30300969
[TBL] [Abstract][Full Text] [Related]
38. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.
Shaish H; Aukerman A; Vanguri R; Spinelli A; Armenta P; Jambawalikar S; Makkar J; Bentley-Hibbert S; Del Portillo A; Kiran R; Monti L; Bonifacio C; Kirienko M; Gardner KL; Schwartz L; Keller D
Eur Radiol; 2020 Nov; 30(11):6263-6273. PubMed ID: 32500192
[TBL] [Abstract][Full Text] [Related]
39. Impact of robotic learning curve on histopathology in rectal cancer: A pooled analysis.
Gachabayov M; Kim SH; Jimenez-Rodriguez R; Kuo LJ; Cianchi F; Tulina I; Tsarkov P; Bergamaschi R
Surg Oncol; 2020 Sep; 34():121-125. PubMed ID: 32891316
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Implications of Pathological Response to Neoadjuvant Chemoradiation in Pathologic Stage III Rectal Cancer.
Karagkounis G; Thai L; Mace AG; Wiland H; Pai RK; Steele SR; Church JM; Kalady MF
Ann Surg; 2019 Jun; 269(6):1117-1123. PubMed ID: 31082910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
